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Causal relationship between microorganism, and psoriasis has never been
demonstrated, although many types of streptococci have been thought to exert
an influence. This paper concerns itself with streptococci of the Lancefield "D"
group known as streptococcus fecalis.
Barber (1) cited a number of instances in which acute psoriasis or an acute
exacerbation of psoriasis followed scarlet fever or a streptococcal infection of the
throat, with a latent sensitization period of 10—21 days prior to the appearance
of the psoriatic lesions. This interval was similar to the lag between throat and
joint involvement in rheumatic fever. Kierland (2) cultured strep. viridans from
the throats of psoriatic patients. After animal inoculations, he concluded that
there was insufficient evidence to incriminate streptococci as the cause of psoria-
sis.
High titre positive agglutination reactions against streptococci of the Lance-
field groups A and G were found by Norrlind (3) in patients with acute gutate
psoriasis. These positive reactions occurred twice as frequently in psoriatic pa-
tients as in non-psoriatic controls. There is, however, a strong possibility that
the positive agglutination reactions were due to secondary infection of the
psoriatic lesions or concurrent pyogenic infection elsewhere. In 1950 (4) he again
considered that he had found the same correlation between psoriasis and strep-
tococci and suggested that modern antibiotics be tried in the treatment of this
disease. Antibiotics of various kinds have been administered to psoriatics for
treatment of other conditions, and with rare exceptions, no beneficial results
from these antibiotics have been noted.
Stokes and Ford (5), reported excellent response in 2 cases of psoriasis when
they were treated with terramycin. This, however, is not the usual experience
in psoriatic therapy.
Correlation between the streptococcus fecalis content of the feces and the
presence of psoriasis was discussed by Swartz in 1943 (6). He observed: (1) pa-
tients having psoriasis have a larger proportion of strep. fecalis in the fecal flora
than do non-psoriatic individuals, due to the fact that many psoriatics have
redundant colons which is conducive to an accumulation of this organism; (2)
full blooded negroes do not have psoriasis; (3) s. fecalis could not be isolated
from the feces of so-called full blooded negroes; (4) a large percentage of pa-
tients with psoriasis have some irregularity of bowel movements and showed
some evidence of stasis in the colon when visualized by a barium enema; (5) ad-
ministration of an autogenous vaccine of s. fecalis had a beneficial effect on
psoriasis, and if given in too large a dose caused a Herxheimer type of reaction.
The purpose of this investigation was to determine whether s. fecalis is present
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in the intestinal tract of negroes. Its importance exists in the fact that there has
been an attempt by Ostrolenk et al (7, 8) to correlate the presence of enterococci
with fecal contamination in the nut meats, frozen food, and freshly packed crab
meat industry. Workers in these fields were predominantly negroes. If the feces
of negroes did not contain s. fecalis, this correlation would obviously be useless.
In addition, attempt was made to determine the effect of administration of an
autogenous vaccine of s. fecalis on psoriatic patients.
BACTERIOLOGY
S. fecalis was first named by Andrews and Ilorden in 1906 and is one of the
Lancefield "D" group of organisms of the division enterococci. The group is
composed of four members: s. zymogenes; s. durans; s. fecalis and s. liquifaciens
and is characterized by their ability to grow at a low of 10 C. and a high of 45
C. with survival at 60 C. for 30 minutes. They grow in the presence of 40 per
cent bile, 0.1 per cent methylene blue and 6.5 per cent sodium chloride, and have
a high degree of resistance to the sulfonamides (9) and penicillin. Differentia-
tions within the group is made on cultural data (10). All behave alike in agglu-
tination reactions (11). S. fecalis, the most common of the enterococci, is a con-
stant inhabitant of the human gastro-intestinal tract.
INVESTIGATIVE METHODS
(1) Samples of feces obtained from 10 very dark, non-psoriatic negroes were
cultured for s. fecalis.
(2) Samples of feces of 10 white non-psoriatic patients were cultured for s.
fecalis.
(3) Samples of feces obtained from 94 white psoriatic patients were cultured
for s. fecalis.
(4) Search was made to find dark so-called full blooded negroes with psoriasis.
(5) Autogenous vaccines of s. fecalis were prepared and standardized at 50
miffion organisms per ml. These were then diluted to 50 thousand organisms per
ml. The vaccine was administered by intracutaneous injections starting with
0.05 cc. of the highest dilution and then increasing the dose gradually to 1.0 cc.
of the vaccine containing 50 million organisms per cc. Subsequent injections
continued on that level. Multiple injection sites were used when the dose went
above 0.2 cc. to avoid excessive pain.
(6) Patients were divided into two groups; one group of 39 patients received
injections twice weekly and another group of 38 patients were treated once a
week.
(7) A stock vaccine of mixed streptococci of the same count as the autogenous
vaccine was administered to 10 psoriatic controls and continued for more than
6 months.
(8) Buffered saline was administered to 7 for patients further control.
(9) Barium enemas were done on 36 psoriatic patients and compared with a
similar number of examinations of non-psoriatic individuals.
(10) An attempt to get a history of irregular bowel movements was made in
66 non-psoriatic controls.
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RESULTS OF INVESTIGATIONS
Comparison of the s. fecalis count in one gram of feces obtained from psoriatic
patients as compared with white and negro non-psoriatic controls is presented in
table 1.
Individual counts varied widely and is consistent with findings of previous
investigators (11).
Vaccines of s. fecalis were administered to 88 of the original groups. Within
one month the number of patients under treatment dropped to 67. At the end
of three months 54 were still under treatment. Remaining under treatment at
the end of a year were 43 patients. Sixteen continued for a total of 18 months,
then the experiment was discontinued.
A compilation and comparison of results between those treated with auto-
genous s. fecalis vaccine and those treated with a vaccine of pooied streptococci
is shown in table 2.
TABLE 1
Average 8. fecalis per gm. of feces millions
Patients with psoriasis 100.7 m.
White controls 107.9 m.
Negro controls 115.4 m.
TABLE 2
CURED IMPROVED NO CHANGE WORSE
No. % No. % No. % No. %
Psoriatics treated with auto-
genous s. fecalis vaccine


















None of the beneficial results below are different than one would expect in a
group of psoriatic patients under any other type of treatment or no treatment
at all. There was no difference noted between the group which received vaccine
once weekly and those which were given the vaccine twice weekly.
In the control series above, two patients stopped treatment after the first few
injections because of exacerbations. The control group of 7 psoriatic patients to
which buffered saline was administered was discontinued because of a lack of
cooperation. Comparison of barium enema findings between psoriatics and non-
psoriatics did not reveal any remarkable differences.
Negroes with psoriasis were not difficult to find. Many of them were extremely
dark and apparently full blooded.
History of irregulatities of bowel movements in patients with non-psoriatic
dermatoses were not essentially different from the type of histories obtained
from patients with psoriasis. All types of variations from so-called normal to
extremes of diarrhea and constipation were elicited in both groups.
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DISCUSSION
Of greatest interest was the Herxheimer type of reactions which developed in
many patients after the initial injections. Similar reactions have been recorded
by Norrlind (12) in his investigation of bacterial sensitization as a factor in
atopic dermatitis. Exacerbations of the psoriatic lesions on occasions were so
severe that some of the patients refused to continue treatment. In many in-
stances the periods of exacerbation occurred several times and necessitated, in
four patients, further dilution of the vaccine. This reaction occurred not only
when the autogenous vaccine was used, but also with the stock streptococcus
vaccine. It did not occur when saline alone was used, although in three cases
lesions did appear at the sites of injection, exhibiting the characteristic Koebner
phenomenon, and it occurred in many of the patients who were treated with
either of the vaccines.
What is the explanation for these exacerbations? (1) Does the streptococci
fecalis play a definite role as an etiologic agent in psoriasis? flit does why did
half of the control group treated with stock streptococcus vaccine develop exac-
erbations after the initial injections? (2) Does this type of reaction represent an
allergic flare-up to an antigen which is common to all streptococci? If it does,
we must assume that psoriasis has, at least, an allergic component, similar to
that described by Norrlind in atopic dermatitis and by Boe (13) in staphylococcic
infections of the skin. In both of these, cutaneous reactions to the various bac-
teria were demonstrated. In the cases of psoriasis treated with s. fecalis vaccine,
this phenomenon also was demonstrated, since .05 cc. of diluted vaccine given
intradermally was essentially a skin test. As a result of the initial injection the
majority of the patients receiving the vaccine developed an erythematous wheal
at the injection site within 24 hours. Furthermore, if such an assumption is
true, one would expect that administration of the vaccine would tend to desen-
sitize the patient, since a bacterial vaccine is in a sense an allergenic extract.
This did not occur. Satisfactory answers are not available to these posed ques-
tions. It is possible that streptococci is one of the etiologic factors, but it is quite
evident that the observations require further elucidation.
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